Suchergebnisse - "Breccia, Massimo"

PubPharm (14)

1

Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib : Long-term 9-year follow-up of 134 patients

enthalten in: American journal of hematology | 2015

von Breccia, M. | Latagliata, R. | Molica, M. | +5

2

Management options for refractory chronic myeloid leukemia : considerations for the elderly

enthalten in: Drugs & aging | 2013

von Breccia, M. | Alimena, G.

3

Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors

enthalten in: Leukemia research | 2013

von Breccia, M. | Alimena, G.

4

Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

enthalten in: Annals of hematology | 2013

von Tiribelli, M. | Latagliata, R. | Luciano, L. | +17

5

Trisomy 8 in Philadelphia chromosome negative cell preceding the evolution of a Philadelphia chromosome positive clone with the same additional change during imatinib treatment : revisiting the role of genetic instability in chronic myeloid leukemia

enthalten in: Leukemia & lymphoma | 2012

von Cannella, L. | Loglisci, G. | Nanni, M. | +6

6

Nilotinib and dasatinib first-line : are we ready for imatinib replacement?

enthalten in: Leukemia research | 2011

von Breccia, M. | Alimena, G.

7

Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib

enthalten in: Leukemia & lymphoma | 2011

von Loglisci, G. | Breccia, M. | Nanni, M. | +9

8

Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients

enthalten in: American journal of hematology | 2010

von Visani, G. | Breccia, M. | Gozzini, A. | +12

9

Hematology : Nilotinib and dasatinib--new 'magic bullets' for CML?

enthalten in: Nature reviews. Clinical oncology | 2010

von Breccia, M.

10

Pleural/pericardic effusions during dasatinib treatment : incidence, management and risk factors associated to their development

enthalten in: Expert opinion on drug safety | 2010

von Breccia, M. | Alimena, G.